194 related articles for article (PubMed ID: 18723764)
21. Vascular smooth muscle G(q) signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension.
Harris DM; Cohn HI; Pesant S; Zhou RH; Eckhart AD
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3072-9. PubMed ID: 17873012
[TBL] [Abstract][Full Text] [Related]
22. The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.
Tanoue A; Nasa Y; Koshimizu T; Shinoura H; Oshikawa S; Kawai T; Sunada S; Takeo S; Tsujimoto G
J Clin Invest; 2002 Mar; 109(6):765-75. PubMed ID: 11901185
[TBL] [Abstract][Full Text] [Related]
23. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes.
Bender SB; Klabunde RE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2281-8. PubMed ID: 17660396
[TBL] [Abstract][Full Text] [Related]
24. Cardiac hyporesponsiveness in severe sepsis is associated with nitric oxide-dependent activation of G protein receptor kinase.
Dal-Secco D; DalBó S; Lautherbach NES; Gava FN; Celes MRN; Benedet PO; Souza AH; Akinaga J; Lima V; Silva KP; Kiguti LRA; Rossi MA; Kettelhut IC; Pupo AS; Cunha FQ; Assreuy J
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H149-H163. PubMed ID: 28526706
[TBL] [Abstract][Full Text] [Related]
25. GRK2 inhibition in heart failure: something old, something new.
Lymperopoulos A; Rengo G; Koch WJ
Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
[TBL] [Abstract][Full Text] [Related]
26. Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.
Woodall BP; Woodall MC; Luongo TS; Grisanti LA; Tilley DG; Elrod JW; Koch WJ
J Biol Chem; 2016 Oct; 291(42):21913-21924. PubMed ID: 27566547
[TBL] [Abstract][Full Text] [Related]
27. Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function.
Vinge LE; Andressen KW; Attramadal T; Andersen GØ; Ahmed MS; Peppel K; Koch WJ; Freedman NJ; Levy FO; Skomedal T; Osnes JB; Attramadal H
Mol Pharmacol; 2007 Sep; 72(3):582-91. PubMed ID: 17573483
[TBL] [Abstract][Full Text] [Related]
28. Norepinephrine- and epinephrine-induced distinct beta2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes.
Wang Y; De Arcangelis V; Gao X; Ramani B; Jung YS; Xiang Y
J Biol Chem; 2008 Jan; 283(4):1799-807. PubMed ID: 18056263
[TBL] [Abstract][Full Text] [Related]
29. GRK2 targeted knock-down results in spontaneous hypertension, and altered vascular GPCR signaling.
Tutunea-Fatan E; Caetano FA; Gros R; Ferguson SSG
J Biol Chem; 2015 Feb; 290(8):5141-5155. PubMed ID: 25561731
[TBL] [Abstract][Full Text] [Related]
30. Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting.
Chen M; Sato PY; Chuprun JK; Peroutka RJ; Otis NJ; Ibetti J; Pan S; Sheu SS; Gao E; Koch WJ
Circ Res; 2013 Apr; 112(8):1121-34. PubMed ID: 23467820
[TBL] [Abstract][Full Text] [Related]
31. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
32. Roles of the G protein-coupled receptor kinase 2 and Rab5 in α
Hernández-Espinosa DA; Reyes-Cruz G; García-Sáinz JA
Eur J Pharmacol; 2020 Jan; 867():172846. PubMed ID: 31811856
[TBL] [Abstract][Full Text] [Related]
33. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
[TBL] [Abstract][Full Text] [Related]
34. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling.
Jean-Charles PY; Yu SM; Abraham D; Kommaddi RP; Mao L; Strachan RT; Zhang ZS; Bowles DE; Brian L; Stiber JA; Jones SN; Koch WJ; Rockman HA; Shenoy SK
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878120
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4.
Theccanat T; Philip JL; Razzaque AM; Ludmer N; Li J; Xu X; Akhter SA
Cell Signal; 2016 Mar; 28(3):190-203. PubMed ID: 26631573
[TBL] [Abstract][Full Text] [Related]
36. Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mesenteric arteries of cirrhotic patients and rats.
Chen W; Sang JY; Liu DJ; Qin J; Huo YM; Xu J; Wu ZY
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):295-304. PubMed ID: 23742775
[TBL] [Abstract][Full Text] [Related]
37. Suppressed G-protein-coupled receptor kinase 2 activity protects female diabetic-mouse aorta against endothelial dysfunction.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Acta Physiol (Oxf); 2013 Jan; 207(1):142-55. PubMed ID: 22925038
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
39. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
[TBL] [Abstract][Full Text] [Related]
40. Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes.
Chalothorn D; McCune DF; Edelmann SE; Tobita K; Keller BB; Lasley RD; Perez DM; Tanoue A; Tsujimoto G; Post GR; Piascik MT
J Pharmacol Exp Ther; 2003 Jun; 305(3):1045-53. PubMed ID: 12649302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
